Issue 2, 2025, Issue in Progress

Retraction: Yiqi Fumai lyophilized injection attenuates doxorubicin-induced cardiotoxicity, hepatotoxicity and nephrotoxicity in rats by inhibition of oxidative stress, inflammation and apoptosis

Abstract

Retraction of ‘Yiqi Fumai lyophilized injection attenuates doxorubicin-induced cardiotoxicity, hepatotoxicity and nephrotoxicity in rats by inhibition of oxidative stress, inflammation and apoptosis’ by Yue Gu et al., RSC Adv., 2018, 8, 40894–40911, https://doi.org/10.1039/C8RA07163B.

Associated articles

Article information

Article type
Retraction
Submitted
03 Jan 2025
Accepted
03 Jan 2025
First published
13 Jan 2025
This article is Open Access
Creative Commons BY license

RSC Adv., 2025,15, 947-947

Retraction: Yiqi Fumai lyophilized injection attenuates doxorubicin-induced cardiotoxicity, hepatotoxicity and nephrotoxicity in rats by inhibition of oxidative stress, inflammation and apoptosis

Y. Gu, A. Ju, B. Jiang, J. Zhang, S. Man, C. Liu and W. Gao, RSC Adv., 2025, 15, 947 DOI: 10.1039/D5RA90003D

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements